<DOC>
	<DOCNO>NCT00142584</DOCNO>
	<brief_summary>The purpose study evaluate long-term safety , tolerability blood pressure effect metoprolol versus nebivolol patient hypertension . These drug may give alone combination drug commonly use treatment hypertension</brief_summary>
	<brief_title>Evaluation Long-Term Safety Tolerability Metoprolol Versus Nebivolol Patients With Hypertension</brief_title>
	<detailed_description>Approximately 50 million Americans hypertension define systolic blood pressure ( SBP ) great equal 140 mmHg and/or diastolic blood pressure ( DBP ) great equal 90 mmHg . To control blood pressure , 2 agent require many patient . The current study randomize , titration-to-effect , open-label , multi center study . Patients randomize either nebivolol metoprolol . The dose randomized treatment titrate need achieve blood pressure control . If necessary , additional antihypertensive agent ( calcium antagonist , diuretic , etc . ) add achieve control . Patients see every 1-3 month approximately 18 month assess long-term safety , tolerability effectiveness nebivolol versus metoprolol .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Nebivolol</mesh_term>
	<mesh_term>Metoprolol</mesh_term>
	<criteria>Completion previous nebivolol study Stage 12 HTN baseline first study Recent myocardial infarction stroke Contraindications beta blocker therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2005</verification_date>
	<keyword>safety tolerability study</keyword>
	<keyword>hypertension</keyword>
	<keyword>beta-blockers</keyword>
</DOC>